Ahmednagar, India

Umesh Bhise

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Umesh Bhise. Retrieved from https://idiyas.com/inventor/umesh-bhise

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Umesh Bhise: Innovator in Pharmaceutical Chemistry

Introduction

Umesh Bhise is a notable inventor based in Ahmednagar, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biological pathways.

Latest Patents

Umesh Bhise holds 2 patents related to fused bicyclic imidazoles. His latest patents describe compounds of formula (I), which include a tautomer or stereoisomer thereof, or a salt thereof. These compounds are recognized for their effectiveness as inhibitors of the Pi3K/Akt pathway, which is crucial in various cellular processes.

Career Highlights

Umesh is currently associated with Bayer Intellectual Property GmbH, where he continues to advance his research and innovation in the pharmaceutical sector. His work has been instrumental in developing new therapeutic agents that can potentially improve treatment outcomes.

Collaborations

Throughout his career, Umesh has collaborated with esteemed colleagues such as Swen Hölder and Armin Zülch. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Umesh Bhise's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the field. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…